1. Institute of Medicine. Committee to study HIV transmission through blood and blood products. In: Leveton LB, Sox Jr HC, Stoto MA, editors. HIV and the blood supply: an analysis of crisis decision-making: consensus study report. Washington, DC: National Academy Press; 1995.
2. Alter HJ, Purcell RH, Holland PV, et al. The relationship of donor transaminase (ALT) to recipient hepatitis: impact on blood transfusion services. JAMA. 1981;246:630–4.
3. Koziol DE, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med. 1986;04:488–95.
4. Stevens CE, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: an analysis of the transfusion-transmitted viruses study. Ann Intern Med. 1984;104:488–95.
5. US Food and Drug Administration. HTLV-1 antibody testing (11/29/88). At
https://www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/otherrecommendationsformanufacturers/memorandumtobloodestablishments/ucm063001.pdf
. Accessed 27 Oct 2017.